ResMed | RMD - Eps Gewinn Pro Aktie

Aktienkurs
219.85
Täglich Wechseln
0.34 0.15%
Monatlich
-2.85%
Jährlich
-6.80%
Q2 Prognose
215.15

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q3 Mar/2026 2.82 2.37 Apr/30
FY2026Q2 Dec/2025 2.81 2.7 2.43 Jan/29
FY2026Q1 Sep/2025 2.55 2.52 2.20 Oct/30
FY2025Q4 Jun/2025 2.55 2.48 2.08 Jul/31
FY2025Q3 Mar/2025 2.37 2.41 2.13 Apr/23




Eps Veränderung Datum
Ansell USD 0.66 0.5 2025-12
Artivion USD -0.02 0.2 2025-12
AtriCure USD 0.06 0.07 2025-12
Baxter International USD 0.44 0.25 2025-12
Cochlear AUD 3.13 0.25 2025-12
Cooper Companies USD 0.66 0.26 2025-12
CSL USD 5.07 3 2025-12
Dexcom USD 0.68 0.07 2025-12
Edwards Lifesciences USD 0.78 0.2 2026-03
Fisher Paykel Healthcare NZD 0.38 0.01 2025-12
Globus Medical USD 1.28 0.1 2025-12
Haemonetics USD 1.31 0.04 2025-12
Idexx Laboratories USD 2.92 0.3 2025-12
Inogen USD -0.25 0.01 2024-09
Insulet USD 1.44 0.2 2025-12
Integra LifeSciences USD 0.83 0.29 2025-12
Intuitive Surgical USD 2.5 0.03 2026-03
Masimo USD -0.18 1.5 2025-12
Medtronic USD 1.36 0.29 2026-01
Philips EUR 0.6 0.24 2025-12
Ramsay Health Care AUD 0.66 0.01 2025-12
ResMed USD 2.81 0.26 2025-12
Sigma Healthcare AUD -0.01 0.01 2024-12
Sonic Healthcare AUD 0.53 0.04 2025-12
Steris USD 2.53 0.06 2025-12
Teleflex USD 1.93 1.74 2025-12
Thermo Fisher Scientific USD 5.44 1.13 2026-03